Tracking the cell transitions that cause cancer

March 6, 2013 by Ashley Mooney
Credit: Tristan Bepler

Researchers think that for cancer to develop, damaged cells have to undergo certain transitions that cause them to spread, or metastasize.
Junior Tristan Bepler, a biology and computer science major, is testing this hypothesis, studying two types of cell transitions scientists have linked to the spread of cancer. He works in the lab of Mariano Garcia-Blanco, professor of molecular genetics and microbiology, and looks at the mesenchymal-to-epithelial transition, or MET, and the epithelial-to-mesenchymal transition, or EMT. Mesenchymal cells are more motile, while epithelial cells tend to be fixed in rows.

The is that when epithelial cells form tumors, like in colon, prostate or , the cells at the edge of the tumor have to turn to for the cancer metastasize. Then, "the mesenchymal cells can leave the tumor, get into the and spread around your body," Bepler said.

In order for cells to latch onto cells in new locations, they have to transition back to epithelial cells through MET. Bepler's research focuses on whether MET or EMT are necessary for metastasis.

Most of Bepler's daily activities involve culturing cells and handling the rats the lab uses in for the research.

The scientists grow tumors in the rats, they inject them under the skin on their flank. "When we're growing tumors, we have to measure the size of the tumors and weigh the rats to make sure they're not gaining too much weight," Bepler said. "Once the tumors get too large, we have to sacrifice the rats and dissect them. We collect their tumors and their lungs, then we can section them and look at fluorescence, which is how we track MET and EMT."

Although the project is in the basic sciences, it has the potential for clinical use. If EMT is necessary for to spread, drugs that block the transition may be effective in treating certain types of cancer. is still a long way down the road, though, Bepler said.

Choosing to study metastasis, rather than viruses, which the lab also investigates, "really wasn't driven by a desire to study cancer at the time," Bepler said. "I really didn't know anything, so I decided I would do the cancer side."

A Durham, N.C. native, Bepler began his lab work the summer before his freshman year. "When you first start working in the lab, you basically work as a lab tech. Your mentor says, 'do this experiment,' and you do the experiment," he said. "It's sometimes hard to feel like what you're doing is important or like you're really involved in the project because you're just working as a lab tech, you're not intellectually involved."

"The key is to get into the biology of what's going on or think about the experiments and then it becomes a lot more interesting, because after a while you come up with good ideas for experiments, and you become a little more independent and can do your own experiments," he said.

Bepler added that he prefers working with , as opposed to mice, because they are more friendly and do not bite as often.

Explore further: New clues to how cancer spreads

Related Stories

New clues to how cancer spreads

June 27, 2011
Cancer cells circulating in the blood carry newly identified proteins that could be screened to improve prognostic tests and suggest targets for therapies, report scientists at the Duke Cancer Institute.

Study helps resolve debate about how tumors spread

November 29, 2012
A team of scientists, led by researchers at the University of California, San Diego School of Medicine, has shown for the first time how cancer cells control the ON/OFF switch of a program used by developing embryos to effectively ...

Signaling pathways point to vulnerability in breast cancer stem cells

June 9, 2011
Whitehead Institute researchers have identified signals from breast epithelial cells that can induce those cells to transition to and maintain a mesenchymal and stem cell-like cell state that imbues both normal and cancer ...

Transition in cell type parallels treatment response, disease progression in breast cancer

January 31, 2013
A process that normally occurs in developing embryos – the changing of one basic cell type into another – has also been suspected of playing a role in cancer metastasis. Now a study from Massachusetts General Hospital ...

Study finds switch that lets early lung cancer grow unchecked

July 11, 2012
Cellular change thought to happen only in late-stage cancers to help tumors spread also occurs in early-stage lung cancer as a way to bypass growth controls, say researchers at Mayo Clinic in Florida. The finding, reported ...

Recommended for you

Could a green sponge hold cancer-fighting secrets?

July 27, 2017
A small green sponge discovered in dark, icy waters of the Pacific off Alaska could be the first effective weapon against pancreatic cancer, researchers said on Wednesday.

Stem cell therapy attacks cancer by targeting unique tissue stiffness

July 26, 2017
A stem cell-based method created by University of California, Irvine scientists can selectively target and kill cancerous tissue while preventing some of the toxic side effects of chemotherapy by treating the disease in a ...

Understanding cell segregation mechanisms that help prevent cancer spread

July 26, 2017
Scientists have uncovered how cells are kept in the right place as the body develops, which may shed light on what causes invasive cancer cells to migrate.

Study uncovers potential 'silver bullet' for preventing and treating colon cancer

July 26, 2017
In preclinical experiments, researchers at VCU Massey Cancer Center have uncovered a new way in which colon cancer develops, as well as a potential "silver bullet" for preventing and treating it. The findings may extend to ...

Compound shows promise in treating melanoma

July 26, 2017
While past attempts to treat melanoma failed to meet expectations, an international team of researchers are hopeful that a compound they tested on both mice and on human cells in a petri dish takes a positive step toward ...

Study may explain failure of retinoic acid trials against breast cancer

July 25, 2017
Estrogen-positive breast cancers are often treated with anti-estrogen therapies. But about half of these cancers contain a subpopulation of cells marked by the protein cytokeratin 5 (CK5), which resists treatment—and breast ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.